FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

347311000001108: Oxybutynin 2.5mg tablets (Sandoz Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17142701000001119 Oxybutynin 2.5mg tablets (Sandoz Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17142801000001111 Oxybutynin 2.5mg tablets (Sandoz Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxybutynin 2.5mg tablets (Sandoz Ltd) Is a Product containing precisely oxybutynin hydrochloride 2.5 milligram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Sandoz Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Sandoz Ltd) Has active ingredient Oxybutynin hydrochloride false Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Sandoz Ltd) Has active ingredient Oxybutynin false Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Sandoz Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Sandoz Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Sandoz Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Sandoz Ltd) Has specific active ingredient Oxybutynin hydrochloride true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Sandoz Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Sandoz Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Oxybutynin 2.5mg tablets (Sandoz Ltd) 56 tablet 4 x 14 tablets Is pack of False Oxybutynin 2.5mg tablets (Sandoz Ltd) Inferred relationship Existential restriction modifier
Oxybutynin 2.5mg tablets (Sandoz Ltd) 56 tablet 4 x 14 tablets Has AMP True Oxybutynin 2.5mg tablets (Sandoz Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start